Condition
Cancer, Lung clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Cancer, Lung clinical trials that are recruiting, at sites in 4 countries (most in United States (4), Canada (1), France (1)). By phase: Early Phase 1 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Cancer, Lung clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Blood microRNA markers for chemotherapy-related peripheral nerve damage in lung and colorectal cancer | — | Clermont-Ferrand | Recruiting | Feb 23, 2026 |
| Personalized PULSAR MRI-guided radiation for central lung tumors | Early Phase 1 | Dallas, Texas | Recruiting | Dec 2, 2024 |
| Testing CPO301 in adults with advanced or metastatic solid tumors | Phase 1 | Los Angeles, California and 13 other locations | Recruiting | Jul 17, 2023 |
| Innovative care program for lung cancer survivors | — | Lexington, Kentucky | Recruiting | May 15, 2023 |
| AI-based precision oncology clinical trial matching and registry | — | Birmingham, Alabama and 67 other locations | Recruiting | Mar 2, 2018 |
All recruiting trials (5)
-
Blood microRNA markers for chemotherapy-related peripheral nerve damage in lung and colorectal cancer
This study will test whether levels of tiny blood molecules called microRNAs can predict how often and how badly patients with lung or colorectal cancer get nerve damage from certain chemotherapies.
-
Personalized PULSAR MRI-guided radiation for central lung tumors
This will test whether personalized, MRI-guided PULSAR radiation given as five widely spaced high-precision doses can safely treat small central primary or metastatic lung tumors.
-
Testing CPO301 in adults with advanced or metastatic solid tumors
This study is testing a new drug called CPO301 to see if it is safe and effective for adults with advanced or metastatic solid tumors, including Non-Small Cell Lung Cancer.
-
Innovative care program for lung cancer survivors
This study is testing a new care program designed to help lung cancer survivors in Kentucky feel better and improve their quality of life compared to standard care.
-
AI-based precision oncology clinical trial matching and registry
This study is testing whether an AI tool can help match cancer patients with the right clinical trials based on their specific cancer details to see if it improves their chances of getting into trials and their overall outcomes.
Related topics
Quick answers
How many Cancer, Lung clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (4 trials), Canada (1 trial), France (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.